SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
12-Jan-18 2:33 PM View: | Opexa Therapeutics, Inc. (ACER) | 12-Dec-17 | Market Purchase | 333,333 | $12.00 | $4,000,000.00 | 16% 2.06M to 2.4M | (78%) |
27-Sep-17 6:34 PM View: | Opexa Therapeutics, Inc. (ACER) | 19-Sep-17 | Acquisition (other) | 2,063,980 | -- | -- | 100% 0 to 2.06M | |
30-Oct-14 8:23 AM View: | Protara Therapeutics, Inc. (TARA) | 27-Oct-14 | Conversion | 1,107,150 | -- | -- | 58% 1.9M to 3.01M | |
30-Oct-14 8:23 AM View: | Protara Therapeutics, Inc. (TARA) | 27-Oct-14 | Conversion | 379,462 | -- | -- | 13% 3.01M to 3.39M | |
30-Oct-14 8:23 AM View: | Protara Therapeutics, Inc. (TARA) | 27-Oct-14 | Purchase | 223,410 | $10.00 | $2,234,100.00 | 7% 3.39M to 3.61M | |
30-Oct-14 8:23 AM View: | Protara Therapeutics, Inc. (TARA) | 27-Oct-14 | Purchase | 76,590 | $10.00 | $765,900.00 | 2% 3.61M to 3.69M | |
30-Oct-14 8:23 AM View: | Protara Therapeutics, Inc. (TARA) | 27-Oct-14 | Exercise (in-the money or at-the-money) | 116,511 | $4.60 | $536,219.00 | 3% 3.69M to 3.81M | |
30-Oct-14 8:23 AM View: | Protara Therapeutics, Inc. (TARA) | 27-Oct-14 | Exercise (in-the money or at-the-money) | 39,932 | $4.60 | $183,779.00 | 1% 3.81M to 3.85M | |
20-Feb-14 8:35 AM View: | Concert Pharmaceuticals, Inc. (CNCE) | 19-Feb-14 | Conversion | 999,138 | -- | -- | 1882% 53.1K to 1.05M | |
20-Feb-14 8:35 AM View: | Concert Pharmaceuticals, Inc. (CNCE) | 19-Feb-14 | Conversion | 342,437 | -- | -- | 33% 1.05M to 1.39M | |
20-Feb-14 8:35 AM View: | Concert Pharmaceuticals, Inc. (CNCE) | 19-Feb-14 | Purchase | 66,287 | $14.00 | $928,018.00 | 5% 1.39M to 1.46M | |
20-Feb-14 8:35 AM View: | Concert Pharmaceuticals, Inc. (CNCE) | 19-Feb-14 | Purchase | 22,713 | $14.00 | $317,982.00 | 2% 1.46M to 1.48M |